Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
3.57
0.00 (0.00%)
4:00 PM ET on May 2, 2016
Delayed at least 20 minutes.
Day High N/A
Day Low N/A
52-Week High 11.65
Volume N/A
Print Friendly